Correlation of Antibody Response to COVID-19 Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.
Not Applicable
Completed
- Conditions
- Covid-19
- Interventions
- Diagnostic Test: COVID-19 Spike Protein IgG Quantitative Antibody (CMIA)
- Registration Number
- NCT06259656
- Lead Sponsor
- Vachira Phuket Hospital
- Brief Summary
The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV.
- Detailed Description
The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV. Sample size is 40 Thai patients at labor room Vachira Phuket Hospital in October - November 2023, who have at least one COVID-19 vaccination before or when pregnant. The Secondary outcome is to study time effect after COVID-19 vaccination and effect of vaccine type on Antibody level.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
- Thai term pregnant women
- 18-45 year old
- At least 1 covid vaccination received
- admission at Vachira Phuket Hospital Labor Room
Exclusion Criteria
- Do not want to participate
- Unstable or Emergency condition
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Thai term pregnant woman who have at least One dose of Covid vaccination COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) Maternal and cord blood was collected to test COVID-19 Spike Protein IgG Quantitative Antibody (CMIA)
- Primary Outcome Measures
Name Time Method COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) Level 1 month Test for correlation of level in maternal and cord blood
- Secondary Outcome Measures
Name Time Method Analysed time effect from last vaccination and type. 1 month Test for time effect after last dose of vaccination
Trial Locations
- Locations (1)
Vachira Phuket Hospital
🇹🇭Phuket, Thailand